Katherine Cox-Flaherty MD ScM

138 posts

Katherine Cox-Flaherty MD ScM

Katherine Cox-Flaherty MD ScM

@KCoxFlaherty

Pulmonary and Critical Care physician at Brown University. Passionate about pulmonary hypertension and sex/gender research. Views are my own.

Providence, RI Beigetreten Ağustos 2022
166 Folgt127 Follower
Katherine Cox-Flaherty MD ScM retweetet
ATS PC Assembly
ATS PC Assembly@ATS_PC·
Dr. Jose Gomez-Arroyo chats with us after an exciting session - “True Grit: Tales of Impactful Science in Drug Developement Clinical Trials Global Registries and Biobanks in PAH”
English
0
5
12
467
Katherine Cox-Flaherty MD ScM retweetet
ATS PC Assembly
ATS PC Assembly@ATS_PC·
A wonderful talk from Dr. Paul Yu about the inspirational discovery and development process for activin ligand traps for PAH at this morning’s True Grit session @ats @SueGuMD ⭐️⭐️
ATS PC Assembly tweet media
English
0
6
26
737
Katherine Cox-Flaherty MD ScM retweetet
Navneet Singh, MD, ScM
Navneet Singh, MD, ScM@navneetsinghmd·
One of my favorite parts of #ATS2024 is being reminded how collaborative our field is! Had such a great time getting feedback on our preliminary work of MELD-Na as a predictor of PAH severity which is mediated by pathways of inflammation. @atsearlycareer @ATS_PC
Navneet Singh, MD, ScM tweet media
English
0
3
18
893
Katherine Cox-Flaherty MD ScM retweetet
ATS PC Assembly
ATS PC Assembly@ATS_PC·
Catch the action on the ground! @mmcirulis chats with Dr. Boucly about her talk this morning on monotherapy or dual therapy in PAH patients with cardiovascular comorbidities 📣
English
1
6
10
1.1K
Katherine Cox-Flaherty MD ScM retweetet
ATS PC Assembly
ATS PC Assembly@ATS_PC·
Wrapping up Legoland with a discussion with @Montanidavid and @mmcirulis about his talk on the highly anticipated results re the impact of genetic background on clinical effect of sotatercept in PAH 🧬
English
0
3
10
928
Katherine Cox-Flaherty MD ScM retweetet
Mark Toshner
Mark Toshner@mark_toshner·
This work has taken 10 years to get out! The genetics of chronic thromboembolic pulmonary hypertension-a genuine global effort in a rare disease. atsjournals.org/doi/10.1164/rc…
English
3
6
24
3.3K
Katherine Cox-Flaherty MD ScM retweetet
Navneet Singh, MD, ScM
Navneet Singh, MD, ScM@navneetsinghmd·
I’m so excited to be sharing our recent publication this morning at the @PVRI Community Call! Please join the discussion- registration is still open: 👇🏽
The Pulmonary Vascular Research Institute@PVRI

We're looking forward to hosting you on our Community Call today at 3PM GMT, with @AlbertaPHdoc, @Tatiana_PVRI, @LucillaPiccari, @SandeepSahayMD, Katrina Barry, Joel James and guests Sergio Caravita, Claudia Baratto, Corey Ventetuolo and @navneetsinghmd 🧵👇

English
0
1
10
576
Katherine Cox-Flaherty MD ScM retweetet
Brown Medicine Pulmonary Vascular Disease
🚨Manuscript alert! Our group is proud to share our work using novel tissue of PAECs taken from RHC balloons to describe transcriptional profiles of living patients with pulmonary hypertension! We learned so much: a thread 🧵
Navneet Singh, MD, ScM@navneetsinghmd

It’s incredible to finally see our work describing transcriptional profiles of PAECs taken from living PH patients! 😍I’m so thankful to my mentors and collaborators. What an education this has been! tinyurl.com/y4vzw632 @ATS_PC @atsearlycareer @PHAssociation

English
1
2
15
1.3K
Katherine Cox-Flaherty MD ScM retweetet
JACC Journals
JACC Journals@JACCJournals·
In this comprehensive #JACCHF study exploring #HFrEF prescribing, clinical inertia is a main contributor to nonintensification within an updated taxonomy classification for suboptimal #GDMT prescribing. bit.ly/473vV8Z
JACC Journals tweet media
English
0
38
81
18.2K
Katherine Cox-Flaherty MD ScM retweetet
ATS PC Assembly
ATS PC Assembly@ATS_PC·
Join us for an exciting webinar: "Career Development - Negotiating Job Offers 101" Friday, December 1 from 3-4:30 pm EST with leaders in the field, tailored to both clinicians and researchers Register via the link below 👇 thoracic.zoom.us/meeting/regist…
English
2
12
22
10.6K